Lumizyme
Payments companies reported to CMS as associated with Lumizyme. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Lumizyme, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Lumizyme
These are the largest totals companies reported as associated with Lumizyme. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Richard Rogers | Greenville, SC | Clinical Genetics (M.D.) | $46,848.34 |
| Chafic Karam | Portland, OR | Neurology (Psychiatry & Neurology) | $35,758.76 |
| Perry Shieh | Los Angeles, CA | Neurology (Psychiatry & Neurology) | $30,192.47 |
| Alberto Santiago Cornier | Santurce, PR | Clinical Genetics (M.D.) | $25,753.89 |
| Salman Bhai | Dallas, TX | Neurology (Psychiatry & Neurology) | $23,399.67 |
| Bassam Malo | Fenton, MO | Neurology (Psychiatry & Neurology) | $20,654.67 |
| Christina Grant | Washington, DC | Pediatrics | $18,298.28 |
| Joseph Ray | Galveston, TX | Clinical Genetics (M.D.) | $17,159.15 |
| Jay Han | Orange, CA | Neuromuscular Medicine (Physical Medicine & Rehabilitation) | $16,663.59 |
| Tahseen Mozaffar | Orange, CA | Neuromuscular Medicine (Psychiatry & Neurology) | $16,499.73 |
Prescribed Lumizyme?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.